SHL Telemedicine is a world-leading provider of telemedicine services with over 25 years of experience, serving over a million users. The company specializes in innovative personal ECG technology and devices, including the smartheart, the first and only personal and mobile 12 lead ECG device in the market. This device enables individuals to perform a full hospital-grade 12 lead ECG without medical assistance and send it to their physician for diagnosis within seconds. SHL's telemedicine solutions are proven to reduce healthcare systems' costs while improving the quality of care for chronic patients.
The smartheart provides a unique mHealth solution for reducing readmission rates of post-heart attack patients, addressing a significant burden for healthcare systems. SHL's FDA-cleared and CE-marked devices are at the forefront of technology, offering advanced telemedicine services that improve patient outcomes and operational efficiency.
Founded in 1987 and headquartered in Tel Aviv, Israel, SHL Telemedicine operates as a public company with a dedicated team of 98 employees. The company's commitment to innovation and quality has established it as a leader in the telemedicine industry.
B2B professionals should contact SHL Telemedicine for cutting-edge telemedicine solutions that improve patient care and reduce healthcare costs. Their innovative ECG technology and mHealth solutions offer significant benefits for healthcare providers and patients alike.
Sales teams selling telemedicine solutions, healthcare providers looking to improve patient care, and partners offering digital health services should reach out to SHL Telemedicine.
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Connect with SHL Telemedicine